In contrast, surviving oligodendrocytes located at the demyelinated lesion edge of MS did not express LC3, indicating that different molecular mechanisms might be involved in demyelinating processes between NHD and MS. The gene discussed is MAP1LC3A; the disease is myeloid sarcoma.